Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos J Guerrero-Muñoz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontiers in Cellular Neuroscience|December 24, 2015
Tau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseMarcos J Guerrero-Muñoz, Julia Gerson, Diana L Castillo-Carranza
Immunotargets and Therapy|July 30, 2016
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?Diana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Rakez Kayed
Biochemical Pharmacology|January 11, 2014
Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteinsMarcos J Guerrero-Muñoz, Diana L Castillo-Carranza, Rakez Kayed
Frontiers in Aging Neuroscience|September 5, 2022
The prion-like transmission of tau oligomers <i>via</i> exosomesNoel A Jackson, Marcos J Guerrero-Muñoz, Diana L Castillo-Carranza
Frontiers in Aging Neuroscience|April 20, 2017
Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial DamageScott S Shafiei, Marcos J Guerrero-Muñoz, Diana L Castillo-Carranza
Biological Psychiatry|February 27, 2018
α-Synuclein Oligomers Induce a Unique Toxic Tau StrainDiana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Urmi Sengupta, et al.
ACS Chemical Neuroscience|October 11, 2013
Design of metastable β-sheet oligomers from natively unstructured peptideMarcos J Guerrero-Muñoz, Diana L Castillo-Carranza, Urmi Sengupta, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 26, 2013
Alzheimer's disease imaging with a novel Tau targeted near infrared ratiometric probeHye-Yeong Kim, Urmi Sengupta, Pin Shao, et al.
Acta Neuropathologica Communications|June 15, 2014
Characterization of tau oligomeric seeds in progressive supranuclear palsyJulia E Gerson, Urmi Sengupta, Cristian A Lasagna-Reeves, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2014
Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seedsDiana L Castillo-Carranza, Julia E Gerson, Urmi Sengupta, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Cellular Neuroscience|December 24, 2015
Tau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseMarcos J Guerrero-Muñoz, Julia Gerson, Diana L Castillo-Carranza
Immunotargets and Therapy|July 30, 2016
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?Diana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Rakez Kayed
Biochemical Pharmacology|January 11, 2014
Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteinsMarcos J Guerrero-Muñoz, Diana L Castillo-Carranza, Rakez Kayed
Frontiers in Aging Neuroscience|September 5, 2022
The prion-like transmission of tau oligomers <i>via</i> exosomesNoel A Jackson, Marcos J Guerrero-Muñoz, Diana L Castillo-Carranza
Frontiers in Aging Neuroscience|April 20, 2017
Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial DamageScott S Shafiei, Marcos J Guerrero-Muñoz, Diana L Castillo-Carranza
Biological Psychiatry|February 27, 2018
α-Synuclein Oligomers Induce a Unique Toxic Tau StrainDiana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Urmi Sengupta, et al.
ACS Chemical Neuroscience|October 11, 2013
Design of metastable β-sheet oligomers from natively unstructured peptideMarcos J Guerrero-Muñoz, Diana L Castillo-Carranza, Urmi Sengupta, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 26, 2013
Alzheimer's disease imaging with a novel Tau targeted near infrared ratiometric probeHye-Yeong Kim, Urmi Sengupta, Pin Shao, et al.
Acta Neuropathologica Communications|June 15, 2014
Characterization of tau oligomeric seeds in progressive supranuclear palsyJulia E Gerson, Urmi Sengupta, Cristian A Lasagna-Reeves, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2014
Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seedsDiana L Castillo-Carranza, Julia E Gerson, Urmi Sengupta, et al.
Pageof 2